Structure of Lansoprazole
CAS No.: 103577-45-3
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Lansoprazole is an inhibitor of proton-pump. It can reduce the gastric acid production of stomach.
Synonyms: AG-1749; A-65006; Lansoprazole, AG-1749, Prevacid, Zoton, Agopton, Bamalite, Opiren
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 103577-45-3 |
Formula : | C16H14F3N3O2S |
M.W : | 369.36 |
SMILES Code : | O=S(CC1=NC=CC(OCC(F)(F)F)=C1C)C2=NC3=C(N2)C=CC=C3 |
Synonyms : |
AG-1749; A-65006; Lansoprazole, AG-1749, Prevacid, Zoton, Agopton, Bamalite, Opiren
|
MDL No. : | MFCD00866873 |
InChI Key : | MJIHNNLFOKEZEW-UHFFFAOYSA-N |
Pubchem ID : | 3883 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Description |
Lansoprazole (AG 1749) is an oral proton pump inhibitor that effectively suppresses gastric acid secretion. Additionally, Lansoprazole (AG 1749) demonstrates potent inhibition of neutral sphingomyelinase (N-SMase), making it a brain-penetrant exosome inhibitor[1][2].
|
Target |
|
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
RAW 264.7 cells | 1-2.5 μM | 4 days | Significantly increased the proportion of large osteoclasts | PMC4703748 |
HEK293 cells | 20 μM | 30 minutes | Enhances polyubiquitination of TRAF6 | PMC4703748 |
Human mesenchymal stromal cells | 20 μM | 2 days | Enhances nuclear accumulation of Runx2 and induces osteoblastogenesis | PMC4703748 |
Human primary white adipocytes | 10 μmol/L | LPZ treatment induced the expression of thermogenic markers UCP1 and PPARGC1A | PMC10985025 | |
Mouse primary subcutaneous white adipocytes | 10 μmol/L | LPZ treatment significantly increased basal, maximal and proton leak respiration and elevated the expression of thermogenic genes | PMC10985025 | |
Mouse primary brown adipocytes | 10 μmol/L | LPZ treatment significantly increased basal, maximal and proton leak respiration and elevated the expression of thermogenic genes | PMC10985025 | |
MRC-5 lung fibroblasts | 10 µM | 72 hours | Lansoprazole showed intracellular activity against Mycobacterium tuberculosis in MRC-5 lung fibroblasts with an IC50 of 1.47 µM | PMC4510652 |
Human microvascular endothelial cells (HMVECs) | 20 μM | 24 hours | To study the effect of PPIs on intracellular ADMA concentration, results showed PPIs increased intracellular ADMA by ~30% | PMC3838201 |
NIH3T3 fibroblasts | 160 μM | 180 seconds | To test the inhibitory effect of lansoprazole on swelling-dependent chloride channels (IClswell), results showed that lansoprazole could block IClswell with an IC50 of 160 μM. | PMC1571856 |
Candida auris AR0390 | 40 µg/mL (108 µM/mL) LNP + 2 µg/mL AmB | 6 hours | To assess the killing kinetics of the AmB/LNP combination, lansoprazole restored the fungicidal properties of AmB against resistant C. auris within 6 hours. | PMC10911247 |
Candida auris AR0390 | 16 µM/mL | 24 hours | To screen for drugs that enhance AmB's antifungal activity, lansoprazole was identified as a potent enhancer of AmB against C. auris AR0390. | PMC10911247 |
Aβ42 fibrils | 2.5–10 μM | 750 s | Evaluation of binding kinetics of lansoprazole with Aβ42 fibrils, showing multiple binding sites | PMC11527973 |
ΑSyn fibrils | 2.5–10 μM | 750 s | Evaluation of binding kinetics of lansoprazole with αSyn fibrils, showing multiple binding sites | PMC11527973 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
C57BL/6J male mice | High-fat diet (HFD)-induced obesity model | Subcutaneous injection | 10 mg/kg | Daily until the completion of the experiments | LPZ treatment slowed body weight gain, reduced fat mass accumulation, increased energy expenditure, improved glucose tolerance and insulin sensitivity, and alleviated hepatic steatosis | PMC10985025 |
BALB/c mice | Acute tuberculosis model | Oral | 300 mg/kg | Twice daily for 9 days | Oral administration of lansoprazole sulfide significantly reduced the bacterial burden of Mycobacterium tuberculosis-infected mice | PMC4510652 |
Sprague–Dawley rats | Femoral fracture model | Oral | 7.5 mg/kg/day | Once daily for 4 weeks | Increased osteoblastogenesis and accelerated fracture healing | PMC4703748 |
C57BL/6J mice | Subcutaneous injection | 30 mg/kg/day | Once daily for 5 weeks | To study the effect of lansoprazole on serum ADMA levels, results showed lansoprazole increased serum ADMA by ~20% | PMC3838201 | |
Female CD-1 mice | Disseminated C. auris infection model | Oral | 300 mg/kg | Once daily for two days | To evaluate the therapeutic efficacy of the AmB/LNP combination in vivo, the combination significantly reduced fungal burden in the kidneys (1.7-log reduction) and improved mouse health. | PMC10911247 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT00299845 | Gastroesophageal Reflux | PHASE4 | WITHDRAWN | - | Osaka University Hospital, Sui... More >>ta, Osaka, 565-0871, Japan Less << |
NCT00458614 | Cystic Fibrosis | PHASE1 | COMPLETED | 2025-04-07 | Arkansas Children's Hospital L... More >>ittle Rock, Little Rock, Arkansas, 72202, United States Less << |
NCT00211614 | Obstructive Sleep Apnea|Gastro... More >>esophageal Reflux Less << | WITHDRAWN | 2025-09-06 | MetroHealth Medical Center, Cl... More >>eveland, Ohio, 44109, United States Less << | |
NCT01512953 | Coronary Stenting | PHASE4 | UNKNOWN | 2025-08-13 | University Hospital of Ferrara... More >>, Ferrara, ER, 44100, Italy Less << |
NCT00390390 | Heartburn | PHASE3 | COMPLETED | 2025-01-07 | Sunbelt Research Group, Mobile... More >>, Alabama, 36608, United States|Arkansas Primary Care Clinic, Little Rock, Alaska, 72204, United States|Radiant Research, Chandler, Arizona, 85225, United States|Radiant Research - Scottsdale, Scottsdale, Arizona, 85251, United States|Edinger Medical Group, Fountain Valley, California, 92709, United States|Gaslamp Medical Center, San Diego, California, 92101, United States|Expresscare Clinical Research, Colorado Springs, Colorado, 80909, United States|Central Florida Clinical Trials inc., Altamonte Springs, Florida, 32714, United States|Tampa Bay Medical Research, Inc., Clearwater, Florida, 33761, United States|Health Awareness Inc., Jupiter, Florida, 33458, United States|University Clinical Research, Inc., Pembroke Pines, Florida, 33024, United States|Palm Beach Research, West Palm Beach, Florida, 33409, United States|Accelovance, Peoria, Illinois, 61602, United States|IRSI, Rockland, Massachusetts, 04841, United States|Prime Care Research, St. Louis, Missouri, 63031, United States|Clinical Research Center of Nevada, Las Vegas, Nevada, 89104, United States|Urgentmed, South Bound Brook, New Jersey, 08880, United States|Wake research associates, Inc, Raleigh, North Carolina, 27612, United States|Piedmont Medical Research, Winston Salem, North Carolina, 27103, United States|Radiant Research, Cincinnati, Ohio, 45236, United States|Wells Institute For Health Awareness, Kettering, Ohio, 45429, United States|Toledo Center for Clinical Research, Sylvania, Ohio, 43560, United States|Durham Physicans, Durham, Pennsylvania, 19047, United States|2222 State Street, Nashville, Tennessee, 37203, United States|Wells Branch Medical Center, Austin, Texas, 78728, United States|Medical Edge Healthcare Group, Dallas, Texas, 75243, United States|Houston, Texas, 77002, United States|Clinical Trials Network, Houston, Texas, 77074, United States|Health Research of Hampton Roads, Newport News, Virginia, 23606, United States|Holston Medical Group, Weber City, Virginia, 24290, United States Less << |
NCT02151786 | Gastric Ulcer, Duodenal Ulcer,... More >> Acute Stress Gastritis, and Acute Gastric Mucosal Lesions Less << | COMPLETED | 2025-03-10 | - | |
NCT02099708 | Gastric or Duodenal Ulcers | COMPLETED | 2025-03-14 | - | |
NCT02099682 | Gastric or Duodenal Ulcers | COMPLETED | 2025-01-14 | - | |
NCT00220909 | Patients Undergoing Elective C... More >>oronary Artery Bypass Graft Less << | PHASE4 | TERMINATED | 2025-01-06 | Temple University School of Me... More >>dicine, Philadelphia, Pennsylvania, 19140, United States Less << |
NCT01135368 | Gastroesophageal Reflux | PHASE4 | COMPLETED | 2025-09-08 | - |
NCT02170207 | Acute Stress Ulcer and Acute G... More >>astric Mucosal Lesions Less << | COMPLETED | 2025-03-10 | - | |
NCT01778101 | Preterm Infants|Gastrointestin... More >>al Reflux Less << | PHASE2 | COMPLETED | 2025-06-13 | Seoul National University Chil... More >>dren's Hospital, Seoul, 110-740, Korea, Republic of Less << |
NCT01270308 | Healthy | PHASE1 | COMPLETED | 2025-12-08 | Bioserve Clinical Research (P)... More >> Ltd, Balanagar, Hyderabad, 500 037, India Less << |
NCT01990339 | Gastroesophageal Reflux Diseas... More >>e With Dyspepsia Symptoms Less << | COMPLETED | 2025-12-10 | - |
Tags: Lansoprazole | AG-1749 | AG1749 | AG 1749 | Proton Pump | Bacterial | Phospholipase | exosome | N-SMase | proton pump inhibitor | N-SMase inhibitor | exosome inhibitor | sphingomyelinase inhibition | 103577-45-3
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL